Vancouver, British Columbia–(Newsfile Corp. – July 7, 2020) – Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (“Sweet Earth“) is pleased to provide an update on its European operations. In 2019 the Company had signed a long-term lease agreement (the “Lease Agreement“) in Los Barrios, Spain, a region renowned for its temperate climate and agricultural industry.
Sweet Earth has strategically secured the location near its European headquarters, which is also located in the province of Cadiz, Spain. The Lease Agreement, which extends for a minimum of five years, allows the Company to secure approximately 22 acres with an option for future lease extension and land expansion. In addition, the Company has recently purchased 450 kilograms of high-grade Earlina 8FC seeds.
Earlina 8FC seed is an industrial hemp strain that’s been authorized for cultivation in the European Union (“EU“). This strain was developed in France and is grown to produce highly nutritious hemp seeds rich in essential oils and beneficial to people and animals. Its key characteristic is a CBD yield of 2-3% with a guaranteed less-than 0.2% THC1 content, an essential European Community requirement. While North American hemp production allows for plants of up to 0.3% THC, the European Industrial Hemp Association (“EIHA“) adheres to more stringent EU policies.
The Federal Law and Policy, International, FDA, Hemp/CBD clearly emphasizes that it is not recommended to import CBD products from outside the EU. Hemp production and CBD products are legal throughout the continent, other than Slovakia2 but laws differ from country to country. Sweet Earth’s expansion into Los Barrios, Spain will allow it to produce locally, leverage its EU distribution relationships, augment research and development for the EU market, and expedite getting products on shelves throughout the continent.
Figure 1: Hemp Cultivation in the EU
To view an enhanced version of Figure 1, please visit:
The EU accounts for approximately 25% of global hemp production.
Sweet Earth has opted to expand into the Spain for its EU strategy.
About Sweet Earth
Sweet Earth is a vertically integrated “farm to shelf” hemp grower with a farm in Applegate, Oregon, that maintains a full line of hemp and CBD products for the US and global market. Its products combine CBD with herbal and organic ingredients, all of which are selected for their beneficial properties to soothe, rejuvenate, and reduce inflammation. In addition to high-end finished products, Sweet Earth prides itself on sustainability by minimizing the use of plastics in both production and packaging.
Sweet Earth’s in-house genetics team has been working on its own proprietary hemp strain. This strain has been grown in its indoor greenhouse resulting in high yielding CBD rich flower. Sweet Earth looks forward to planting this new strain outdoors for the 2020 season. Sweet Earth products are sold on its website: www.sweetearthcbd.com.
ON BEHALF OF THE BOARD
For additional information contact:
Amrik Virk / President and Director
Telephone: (604) 765-9640
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/59241
Sixth Wave Continues Phase 2 Rapid COVID Test Development and Receives Funding from Nova Scotia COVID-19 Response Council
Halifax, Nova Scotia–(Newsfile Corp. – October 27, 2020) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the “Company”) is pleased to announce that it has received a $250,000 contribution from the Nova Scotia COVID-19 Response Council (“NSCRC”) for the development of its proposed AMIPs™ technology for the rapid detection of viruses such as SARS-CoV-2 (“SARS-CoV-2” or the “Virus“). AMIPs™ is based on Sixth Wave’s patented and patent-pending molecularly imprinted polymer systems.
Under the terms of the Agreement, dated October 22, 2020, Sixth Wave will continue to develop an Accelerated Molecularly Imprinted Polymer (the “AMIPs™“) specifically for the purpose of quickly and selectively binding to the Virus. The proposed technology also contemplates the rapid delivery of a visual and/or electronic response upon the detection and verification of the Virus. The Company’s intention is to incorporate the AMIPs™ technology into a several rapid-detection products, including rapid virus test kits, SmartMask™, as well as air and water monitoring systems. The ability to have the AMIPs™ detection and reporting directly integrated into devices such as Personal Protective Equipment (PPE’s) will seamlessly provide the detection and the ability to automatically disseminate results for use in outbreak tracking and contact tracing (as may be implemented by appropriate Government agencies). The development of the air monitoring technology is the subject of the Company’s previously approved and announced (June 15, 2020) collaboration with York University and Centre Technologique des Residus Industriels which has received support from the Natural Sciences and Engineering Research Council of Canada (“NSERC”).
This Project represents the first outside funding in the development of the Company’s proposed AMIPs™ virus detection technology, and expands the SIXW footprint in Nova Scotia. As previously announced (May 15, 2020), SIXW has already engaged Neocon International Inc., a premier manufacturing company in Dartmouth to commercialize the SmartMask™ product. Moreover, SIXW has executed a Memorandum of Understanding with Dalhousie University to explore near term opportunities to establishing a research and development presence in the Province.
“Our sincere appreciation to the Province of Nova Scotia for its participation in this project,” said Dr. Jon Gluckman, CEO of Sixth Wave. “Sixth Wave has a substantial history of delivering similarly complex MIP based solutions within limited timelines, as evidenced by our explosives detection wipes and bacterial pathogen diagnostic tools. We welcome this opportunity to once again prove the utility of molecular imprinting as a detection and diagnostic tool, especially in circumstances of such importance to public health and security.”
“MIP technology is well documented in the scientific literature as being a comparatively fast and reliable diagnostic tool,” said Garrett Kraft Ph.D., head of the Sixth Wave project. “MIP-based analytical technologies are also known for their flexibility, durability and accuracy. Polymer substrates demonstrate resilience under adverse conditions, and do not require climate-controlled storage as many antibody based tests do. They can therefore be readily applied to a host of materials, fabrics and other test media. These attributes along with low cost and production scalability have the potential to set AMIPs™ apart from traditional PCR and immunoassay tests.”
The company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 coronavirus) at this time. AMIPs tests produced for personal use or point of care use will be subject to regulatory approval.
The Project has a number of objectives, culminating in the development of a Molecularly Imprinted Polymer (“MIP“) formulation with measurable binding of inactivated SARS-CoV-2 in a buffer solution with limits of detection less than 15,000 virus particles / mL (comparable to several other commercially available diagnostic technologies) and a basic colorimetric response using protein labeling chemistry. Clinically relevant viral loads have been determined to be approximately 15,000 virus particles / mL. Although a MIP for the detection of SARS-CoV-2 has not previously been developed, other virus imprinted polymers have demonstrated detection limits as low as 105 virus particles / mL.
Overall, the Company’s objectives for the COVID-selective AMIPs™ include:
- Flexibility – The ability to analyze a significant variety of field samples such as specimens garnered from bodily fluids, breath, air, waste streams, and contact surfaces;
- Speed – The ability to detect and to communicate an electronic or visual signal almost immediately upon positive diagnosis;
- Ease Of Use – The ability to integrate with a variety of devices not requiring specialized training, and
- Low Cost – enabling widespread and frequent testing that will allow for safe return to daily activities and outbreak management.
The Company’s COVID-19 Project represents the first step in the development of a flexible platform which can be adapted to detect virtually any virus. For more information on the proposed AMIPs™ technology and associated fundamental and device-related patent applications, see: www.amips.com.The overall budget for this Project totals $770,000, of which $250,000 will be funded through the contribution by the NSCRC.
The Company’s molecularly imprinted polymer technology is also being commercialized in the mining and cannabis sectors.
About Sixth Wave
Sixth Wave is a nanotechnology company with patented technologies that focus on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs). The Company is in the process of commercial roll out of its Affinity™ cannabinoid purification system, as well as, IXOS®, a line of extraction polymers for the gold mining industry. The Company is in the development stages of a rapid diagnostic test for viruses under the Accelerated MIPs (AMIPS™) label.
Sixth Wave can design, develop and commercialize MIP solutions across a broad spectrum of industries. The company is focused on nanotechnology architectures that are highly relevant for detection and separation of viruses, biogenic amines and other pathogens, for which the Company has products at various stages of development.
For more information about Sixth Wave, please visit our web site at: www.sixthwave.com
ON BEHALF OF THE BOARD OF DIRECTORS
Jonathan Gluckman, Ph.D., President & CEO
For information, please contact the Company:
Phone: (801) 582-0559
This press release includes certain statements that may be deemed “forward-looking statements” including statements regarding the planned use of proceeds and performance of the AMIPs™ technologies. All statements in this release, other than statements of historical facts, that address future events or developments that the Company expects, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. In particular, successful development and commercialization of the AMIPs™ technology are subject the risk that the AMIPs™ technology may not prove to be successful in detecting virus targets effectively or at all, uncertainty of medical product development, uncertainty of timing or availability of required regulatory approvals, lack of track record of developing products for medical applications and the need for additional capital to carry out product development activities. The value of any products ultimately developed could be negatively impacted if the patent is not granted. The Company has not yet completed development of a prototype for the product that is subject of its patent application and has not yet applied for regulatory approval for the use of this product from any regulatory agency.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/66918
Curtis Mathes to Present a Live Webinar for Cannabis Science & Technology
The Curtis Mathes Corporation (OTC: TLED) will be presenting a live webinar on November 3rd in collaboration with the peer-reviewed technical journal, Cannabis Science & Technology. The presentation, entitled “Environmental and Genetic Factors that affect the quality of Cannabis and Hemp”, will be delivered by Dr. Zacariah Hildenbrand along with a live Q&A session.
“We are thrilled to share this educational webcast with our audience as well as the knowledge and thought-leadership from one of our esteemed editorial advisory board members, Dr. Zacariah Hildenbrand,” said Meg L’Heureux, Editor-in-Chief of Cannabis Science & Technology.
“It is always a tremendous honor to disseminate new information regarding the interplay between plants and the environment,” remarked Zacariah Hildenbrand, Curtis Mathes Director and Chief Scientific Officer, “This webinar hosted by Cannabis Science & Technology is an excellent opportunity for us to discuss our latest lighting technologies and ongoing research efforts.”
“Science and research are entrenched in our DNA at Curtis Mathes,” said Robert Manes, President & COO of Curtis Mathes, “Webinars like this allow us to connect with potential collaborators while educating prospective clients on the science of horticultural lighting.”
Santa Cruz Dispensary, KindPeoples Partnering with Cannabis Brands to Offer Fire Relief Program
Santa Cruz, California–(Newsfile Corp. – October 27, 2020) – California’s wildfire season has brought unprecedented devastation and loss to so many this year. In Santa Cruz, the CZU Lightning Complex Fire destroyed more than 900 homes and at its most ferocious, required the evacuation of tens of thousands of people.
At KindPeoples, the largest cannabis retailer in Santa Cruz County, we have been heartened by the tremendous acts of bravery shown by firefighters and first responders and shared in the heartache of the individuals and families impacted by the wildfires.
“We are grateful to the firefighters who worked tirelessly to contain the wildfires in Santa Cruz and are continuing the dangerous work at hotspots throughout our state,” said Khalil Moutawakkil, KindPeoples Co-CEO. “After seven months of living through a pandemic and then confronting the fury of wildfires, we knew we had to do our part in supporting local evacuees and the organizations that are helping the firefighters and localities impacted by fires across California.”
During the month of September, in addition to a company donation that went to local charities supporting Santa Cruz County residents impacted by the CZU Lightning Complex Fire, KindPeoples offered a 25% off store-wide discount to local evacuees. More than 700 individuals redeemed the discount, amounting to $28,730 in customer savings.
Starting Thursday, October 1, when shoppers purchase select items from the following brands, a portion of the sale will be donated to organizations that support restoration and wildfire education, firefighters and communities impacted by the wildfires locally and throughout California.
Participating brands include: Heavy Hitters, Dollar Dose, Kanha Treats, Chemistry, Big Pete’s Treats, Buddies, Sensi Chews, Yummi Karma, Papa & Barkley, and High Gorgeous.
Products that are a part of the program are identified by a “Fire Relief” sticker.
“We are so honored to be a part of KindPeoples Fire Relief Program. Bringing cannabis brands together for a collective goal is what it’s all about, and we are excited to see what an impact we can make together,” said Kirstie Price, regional manager for Heavy Hitters. “The Santa Cruz community has given us so much over the years, this initiative is one of a handful of small steps we are taking to offer a little something back. We are thankful that our local team members have not been directly impacted by the wildfires.”
KindPeoples is locally-owned and operated, independently-funded, with two locations in Santa Cruz: 533 Ocean Street, Santa Cruz, 95060 and 3600 Soquel Avenue, Santa Cruz, 95062. Founded in 2014, KindPeoples was the first state-licensed cultivator, manufacturer, distributor, retailer and micro-business in Santa Cruz.
Since its opening, KindPeoples has focused on being the top cannabis retailer in the region and has been voted each year the “best cannabis dispensary” in Santa Cruz County by the local community in the Good Times readers’ poll, “Best Of”, Santa Cruz County’s largest circulating newspaper. KindPeoples stocks professionally curated, top-shelf, in-demand cannabis and CBD products.
Roseann Cattani – PR Specialist,
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/66853
Cannabis4 weeks ago
MustGrow Commences Banana ‘Panama Disease’ Testing in Colombia
Cannabis3 weeks ago
Bud & Tender® raise testing and quality standards for best CBD oil in the UK
Cannabis3 weeks ago
The World’s Greatest Weight Loss Secret May be Psilocybin
Cannabis4 weeks ago
MediPharm Labs Secures 100% Ownership of its Australia Subsidiary, Poised for New Wave of Global Medicinal Cannabis Growth
Cannabis2 weeks ago
Aither Ingredients Announces Joint Venture With Thar Process Intended to Disrupt the Canadian Cannabis-based Ingredient Market
Cannabis4 weeks ago
WeedMD Reports Second Quarter 2020 Financial Results and Closes $30 Million Credit Facility with LiUNA Pension Fund
Cannabis4 weeks ago
PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND
Cannabis4 weeks ago
Christina Lake Announces Commencement of Trading on the CSE